Marketing-authorisation holder
Zydus Lifesciences Limited
23 medicines in 2 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder
23 medicines in 2 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
23 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMMONIUM LACTATE12% base · Lotion | Ammonium | United States | Marketed | 2002 |
| CANDESARTAN CILEXETIL16mg | 32mg | 4mg | 8mg · Tablet | Candesartan cilexetil | United States | Marketed | 2013 |
| FINASTERIDE AND TADALAFIL5mg; 5mg · Capsule | Finasteride, Tadalafil | United States | Marketed | 2024 |
| FLUDROCORTISONE ACETATE0.1mg · Tablet | Fludrocortisone | United States | Marketed | 2002 |
| JAYTHARI18mg | 30mg | 36mg | 6mg · Tablet | Deflazacort | United States | Marketed | 2025 |
| KETOCONAZOLE2% · Shampoo | Ketoconazole | United States | Marketed | 2004 |
| KETOROLAC TROMETHAMINE10mg · Tablet | Ketorolac | United States | Marketed | 1997 |
| MIDODRINE HYDROCHLORIDE10mg | 2.5mg | 5mg · Tablet | Midodrine | United States | Marketed | 2003 |
| PALBOCICLIB100mg | 125mg | 75mg · Tablet | Palbociclib | United States | Not marketed | 2024 |
| ZDS-BRIVARACETAM25 mg · Tablet | Brivaracetam | Canada | Authorised | |
| ZDS-BRIVARACETAM75 mg · Tablet | Brivaracetam | Canada | Authorised | |
| ZDS-BRIVARACETAM50 mg · Tablet | Brivaracetam | Canada | Authorised | |
| ZDS-BRIVARACETAM100 mg · Tablet | Brivaracetam | Canada | Authorised | |
| ZDS-IVERMECTIN CREAM1 % / w/w · Cream | Ivermectin | Canada | Marketed | 2026 |
| ZDS-LIOTHYRONINE25 mcg · Tablet | Liothyronine sodium | Canada | Marketed | 2026 |
| ZDS-LIOTHYRONINE5 mcg · Tablet | Liothyronine sodium | Canada | Marketed | 2026 |
| ZDS-MESALAMINE SUPPOSITORIES1000 mg · Suppository | Mesalazine | Canada | Marketed | 2026 |
| ZDS-VARENICLINE1 mg · Tablet | Varenicline | Canada | Marketed | 2026 |
| ZDS-VARENICLINE0.5 mg · Tablet | Varenicline | Canada | Marketed | 2026 |
| ZIPRASIDONE HYDROCHLORIDE20mg base | 40mg base | 60mg base | 80mg base · Capsule | Ziprasidone | United States | Marketed | 2012 |
| ZITUVIMET1gm; 50mg | 500mg; 50mg · Tablet | Metformin, Sitagliptin | United States | Marketed | 2023 |
| ZITUVIMET XR1gm; 100mg | 1gm; 50mg | 500mg; 50mg · Tablet, extended release | Metformin, Sitagliptin | United States | Marketed | 2024 |
| ZITUVIO100mg | 25mg | 50mg · Tablet | Sitagliptin | United States | Marketed | 2023 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 13 | 13 | 0 | CompaniesAll medicines |
| Canada | 10 | 10 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.